Preventive effects of Korean red ginseng on experimentally induced colitis and colon carcinogenesis

Hoon-Jeong Shin1, Do-Hee Kim2, Xiancai Zhong3

  • 1Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea.

Insights

Korean Red Ginseng (KRG) ameliorates colitis and colon cancer in mice by reducing inflammation and inhibiting key cancer-promoting molecules. This suggests KRG is a potential natural chemopreventive agent for colon cancer.

Area of Science:

  • Gastroenterology
  • Oncology
  • Pharmacology

Background:

  • Inflammation-associated colon cancer is a significant health concern.
  • Chemoprevention strategies are crucial for reducing cancer incidence.
  • Korean Red Ginseng (KRG) has demonstrated chemopreventive properties.

Purpose of the Study:

  • To investigate the effects of KRG on dextran sulfate sodium (DSS)-induced colitis.
  • To evaluate KRG's efficacy in preventing azoxymethane (AOM) plus DSS-induced colon carcinogenesis.
  • To elucidate the molecular mechanisms underlying KRG's effects.

Main Methods:

  • Male C57BL/6J mice were fed a diet containing 1% KRG or a standard diet.
  • Colitis was induced using 3% DSS in drinking water.
  • Colon carcinogenesis was induced by AOM injection followed by DSS promotion.
  • Expression of COX-2, iNOS, c-Myc, and Cyclin D1 was analyzed.
  • Activation of NF-κB and STAT3 pathways was assessed.

Main Results:

  • KRG treatment ameliorated DSS-induced colitis symptoms, including weight loss and rectal bleeding.
  • KRG significantly reduced colon tumor incidence, multiplicity, and size in the AOM/DSS model.
  • KRG inhibited the expression of COX-2, iNOS, c-Myc, and Cyclin D1.
  • KRG suppressed the activation of NF-κB and STAT3 signaling pathways.

Conclusions:

  • KRG demonstrates protective effects against colitis and inflammation-associated colon cancer in mice.
  • KRG exerts its chemopreventive effects by inhibiting inflammatory mediators and oncogenic signaling pathways.
  • KRG is a potential candidate for the chemoprevention of colon cancer.